W., Ustione, A., Lavagnino, Z
SE-SA reviewed the full text and gave insights on the discussion of animal models
Effects of GLP-1 RAs on gut microbiota: preclinical and clinical evidence The gut microbiota plays a central role in metabolic regulation, particularly in lipid and energy homeostasis, and its alteration is increasingly recognized as a risk factor for obesity, T2D and cardiovascular disease ( Bacillota (formerly Firmicutes ), Bacteroidota (formerly Bacteroidetes) , and Proteobacteria , with obesity-associated patterns often reflecting decreased microbial diversity and loss of beneficial taxa ( Given this evidence, targeting the gut microbiota has emerged as a potential strategy for preventing or ameliorating metabolic diseases, including T2D and dyslipidemia ( Bacillota and Bacteroidota , may influence insulin sensitivity partly through modulation of GLP-1 secretion
We all want to see a change to the current inappropriate and outdated scheduling of psychedelics
Understanding the distinct mechanisms and indications of each treatment is essential when considering their use together, particularly as Mounjaro's effects on appetite and food intake may impact overall nutritional status
2Gluten-free according to EU Regulation
